New insights shed light on managing ADHD as a long-term condition in children and adults

While ADHD remains a persistent neurodevelopmental disorder, recent research highlights evolving approaches to treatment and the potential for symptoms to diminish over time, offering renewed hope for families navigating this lifelong condition.

For many families, the start of the school year brings a familiar anxiety if a child has attention-deficit/hyperactivity disorder. The condition can make lessons, homework and daily routines difficult, but specialists say the diagnosis is not something that simply disappears on command. It is better understood as a neurodevelopmental disorder that can be managed effectively, rather than cured in the classic sense. The CDC says treatment depends on age, with behaviour therapy first for children under 6 and combined medication and behaviour therapy for those 6 and older.

That approach reflects a broad medical consensus. The American Academy of Pediatrics recommends a tailored treatment plan that may include medication, parent training in behaviour management and counselling, with close coordination between families, teachers and clinicians. In practice, medication can sharply reduce impulsivity and improve attention, while behavioural strategies help children build routines and coping skills. The CDC also notes that some medicines can cause side effects such as sleep problems or reduced appetite, which is why follow-up matters.

The idea that ADHD always persists unchanged into adulthood is also too simple. According to National Institute of Mental Health research, most children who receive treatment improve over time, although early gains do not necessarily prevent later difficulties in adolescence. Other studies suggest that symptoms may fade for some people, only to return later, while a smaller share reach full remission. WebMD notes that remission can happen in adulthood, but that many people continue to have symptoms or are diagnosed only later in life.

Research from Johns Hopkins also shows why results can look encouraging in the short term. In a study of lisdexamfetamine dimesylate, many children achieved a clinical response and remission during treatment, and a large proportion maintained improvement at later assessments. Even so, experts stress that ADHD management usually works best as a long-term effort, not a one-off intervention. For parents, that means the goal is rarely to erase the diagnosis entirely; it is to reduce its impact early, before it shapes a child’s learning, confidence and behaviour at home and in class.